Login

I cannot remember my username

Our New Website Is Here!
As part of our merger with St. Paul Research, we’ve created a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through our analysts’ combined insight, expertise, and perspective. Go to my.stpaulresearch.com to access our new site.

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now...

In Breakthrough Technology Alert, Ray Blanco tirelessly researches these exciting new breakthrough technologies and tells you exactly what you need to do to profit from them.

A New “Dahn” for Our Breakthrough Battery Play

Ray Blanco
By Ray BlancoPosted January 19, 2021

Last August we connected the dots on a battery company that had huge potential to be partnered up with the Fortune 500 company Tesla. Now it seems like our prediction paid off…

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

LoginGet Access

Ray Blanco

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Related Posts

New Data From Echo Therapeutics

Patrick Cox
By Patrick CoxPosted May 2, 2012

I've been waiting not so patiently for the first data from Echo Therapeutics' clinical trials of its Symphony glucose monitoring system in critical care patients. We now have that data, which is great, so I'd like to review the implications. First of all, I assume that you know that the Symphony tCGM System is a needle-free noninvasive, wireless, transdermal continuous glucose monitoring technology. It consists of a small device that precisely and painlessly abrades the top dead layer of skin, stopping at the top of the epidermis, where it can measure such things as blood sugar levels. To accomplish this rather impressive task, it uses an electronic sensing system attached to a replaceable microplane to measure changes in electrical conductivity of the skin. You place this device on some area of skin and push a button. It whirrs painlessly and stops automatically.

TOPICS | , , ,

Rebooting Stem Cell Technology and An Update On Important Parkinson’s Data

Ray Blanco
By Ray BlancoPosted October 1, 2013

There's earth-shattering news at our favorite regenerative medicine company this week. The company just announced that it has closed the deal on acquiring extensive stem cell assets. It all started in the 1990s. Some of the original, foundational stem cell technology was developed at a company under the supervision of the two “godfathers” of regenerative medicine.

TOPICS | , , , ,